Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCroda International Regulatory News (CRDA)

Share Price Information for Croda International (CRDA)

Share Price is delayed by 15 minutes
Get Live Data
3,112.00    -6.00 (-0.19%)
Bid:
3,122.00
Ask:
3,124.00
Spread: 2.00 (0.064%)
Market Cap: £4.34b
CRDA Live PriceLast checked at - London Stock Exchange

Intraday Croda International Share Chart

Q1 2010 Trading Statement

28 Apr 2010 07:00

RNS Number : 9062K
Croda International PLC
28 April 2010
 



28 April 2010

 

Croda International Plc

First quarter trading statement

 

Martin Flower, Chairman of Croda International Plc, is due to provide the following update on first quarter trading at today's Annual General Meeting:

 

"At the time of our preliminary results in February we reported that the strong trading performance seen in the second half of 2009 had continued into 2010. We are now able to report record quarterly sales and profits in both Consumer Care and Industrial Specialities.

 

Group sales increased 14.7% to £264.7m (2009: £230.8m) despite adverse currency translation of 4.1%, with overall volumes increasing 26.0%.

 

Group pre-tax profit from continuing operations almost doubled to £42.4m (2009: £21.7m).

 

On a segmental basis, Consumer Care operating profit was up 20.6% to £34.6m (2009: £28.7m) despite challenging 2009 comparatives. Underlying sales increased strongly in both Personal Care and Health Care but Crop Care sales were down in line with the market. Overall sales increased to £130.0m, up 1.4% on last year's figure of £128.2m, despite the adverse currency translation.

 

Industrial Specialities reversed last year's £2.4m loss to record an operating profit of £10.5m with almost all areas seeing significant revenue and profit increases. Volumes increased dramatically and this is driving the 31% increase in revenues to £134.7m (2009: £102.6m).

 

As a consequence of the cash restructuring costs from the closures of both Bromborough and Wilton and adverse currency translation of £5.8m, net debt was little changed from the year end at £292.7m.

 

This is a very strong performance across the business and reflects both robust demand for our products globally and the benefits of the cost cutting activity we have undertaken since the acquisition of Uniqema. However, the buoyant trading conditions we have experienced have been seen across the chemical sector, suggesting an element of restocking. Furthermore, prior year comparatives do get tougher in the second half. We also expect to see raw material inflation begin to increase in many areas.

 

Notwithstanding the above, the robust trading has continued into quarter two and we remain confident of achieving significant progress throughout the remainder of 2010."

 

 

For further information, please contact:

 

Mike Humphrey, Group Chief Executive

Tel: 01405 860551

Sean Christie, Group Finance Director

Charlie Armitstead, Financial Dynamics

Tel: 07703 330 269

 

The company will host a conference call for analysts at 8.00am (BST) today:

Dial-In: +44 (0)1452 542 303

Please quote "Croda International"to gain access to the call

 

 

Croda International Plc

Unaudited income statement before tax and exceptional items

31 March 2010

£m

3 months to

3 months to

31 March

31 March

2010

2009

Change

Consumer Care

130.0

128.2

+1.4%

Industrial Specialities

134.7

102.6

+31.3%

Revenues from continuing operations

264.7

230.8

+14.7%

Consumer Care

34.6

28.7

+20.6%

Industrial Specialities

10.5

(2.4)

n/a

Operating profit from continuing operations

45.1

26.3

+71.5%

Net bank and loan interest payable

(2.8)

(4.5)

Net retirement benefit scheme financing

0.1

(0.1)

Profit before tax from continuing operations

42.4

21.7

+95.4%

Continuing operations operating margin

17.0%

11.4%

Analysis of turnover uplift for continuing operations

Continuing operations sales volumes

+26.0%

Currency impact

-4.1%

Price/mix

-7.2%

+14.7%

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFRSLIDFII
Date   Source Headline
13th Nov 20174:01 pmRNSDirector/PDMR Shareholding
31st Oct 20177:00 amRNSTrading Update for the Third Quarter 2017
17th Oct 20179:23 amRNSAppointment of KPMG LLP as External Auditor
11th Oct 20174:59 pmRNSDirector/PDMR Shareholding
4th Oct 20172:36 pmRNSDirector/PDMR Shareholding
14th Sep 20171:50 pmRNSDirector/PDMR Shareholding
12th Sep 20172:17 pmRNSDirector/PDMR Shareholding
11th Aug 20172:20 pmRNSDirector/PDMR Shareholding
25th Jul 20177:00 amRNSResults for the six months ended 30 June 2017
11th Jul 20174:22 pmRNSDirector/PDMR Shareholding
11th Jul 20173:26 pmRNSDirector/PDMR Shareholding
14th Jun 20172:58 pmRNSDirector/PDMR Shareholding
2nd Jun 20175:45 pmRNSDirector/PDMR Shareholding
22nd May 20173:35 pmRNSHolding(s) in Company
19th May 20174:34 pmRNSHolding(s) in Company
18th May 20174:27 pmRNSHolding(s) in Company
15th May 20176:01 pmRNSHolding(s) in Company
15th May 20175:46 pmRNSDirector/PDMR Shareholding
15th May 20175:31 pmRNSDirector/PDMR Shareholding
15th May 20175:23 pmRNSDirector/PDMR Shareholding
15th May 20175:16 pmRNSDirector/PDMR Shareholding
15th May 20175:13 pmRNSDirector/PDMR Shareholding
15th May 20175:06 pmRNSDirector/PDMR Shareholding
15th May 20175:04 pmRNSDirector/PDMR Shareholding
15th May 20174:56 pmRNSDirector/PDMR Shareholding
15th May 20174:14 pmRNSDirector/PDMR Shareholding
15th May 20171:57 pmRNSTransaction in Own Shares
11th May 20173:01 pmRNSDirector/PDMR Shareholding
27th Apr 201710:09 amRNSResult of AGM
26th Apr 20177:00 amRNSTrading Update for the First Quarter 2017
11th Apr 20173:35 pmRNSDirector/PDMR Shareholding
23rd Mar 20173:27 pmRNSDirector/PDMR Shareholding
20th Mar 20175:45 pmRNSAnnual Financial Report
16th Mar 20173:45 pmRNSDirector/PDMR Shareholding
13th Mar 20172:20 pmRNSDirector/PDMR Shareholding
10th Mar 20174:39 pmRNSDirector/PDMR Shareholding
9th Mar 20174:53 pmRNSDirector/PDMR Shareholding
9th Mar 20179:50 amRNSDirector/PDMR Shareholding
28th Feb 20177:02 amRNSDr Keith Layden to become a Non-Executive Director
28th Feb 20177:00 amRNSResults for the year ended 31 December 2016
14th Feb 201710:37 amRNSDirector/PDMR Shareholding
11th Jan 20174:06 pmRNSDirector/PDMR Shareholding
20th Dec 20165:25 pmRNSDirector/PDMR Shareholding
13th Dec 20165:23 pmRNSDirector/PDMR Shareholding
24th Nov 20162:39 pmRNSHolding(s) in Company
21st Nov 20164:12 pmRNSDirector/PDMR Shareholding
11th Nov 20163:01 pmRNSDirector/PDMR Shareholding
3rd Nov 20167:00 amRNSTrading update for the third quarter of 2016
2nd Nov 20162:59 pmRNSHolding(s) in Company
1st Nov 201611:19 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.